ACT Advisors’s Heron Therapeutics HRTX Stock Holding History

ACT Advisors’s Portfolio HRTX Stock Details HRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$32.2K	Sell
2025 Q2	$53.1K	Buy
2025 Q1	$56.3K	Hold
2024 Q4	$39.1K	Hold
2024 Q3	$50.9K	Buy
2024 Q2	$77.5K	Hold
2024 Q1	$61.3K	Hold
2023 Q4	$37.6K	Buy